Clinical Trials Directory

Trials / Sponsors / CytRx

CytRx

Industry · 9 registered clinical trials.

StatusTrialPhaseStarted
TerminatedFirst Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer
Stage IIIB Non-small Cell Lung Cancer With Pleural Effusion, Stage IV Non-small Cell Lung Cancer
Phase 22011-04-01
CompletedStudy of Bafetinib (INNO-406) as Treatment for Patients With Hormone-Refractory Prostate Cancer
Hormone Refractory Prostate Cancer
Phase 22010-08-01
CompletedStudy of Bafetinib as Treatment for Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)
B-Cell Chronic Lymphocytic Leukemia
Phase 22010-06-01
WithdrawnINNO-206 in Patients With Small Cell Lung Cancer (SCLC)
Small Cell Lung Cancer
Phase 22008-05-01
CompletedSafety, Efficacy, & Pharmacokinetic Study of Tamibarotene to Treat Patients With Relapsed or Refractory APL
Acute Promyelocytic Leukemia
Phase 22007-09-01
CompletedSafety and Tolerability Study of INNO-406 to Treat Chronic Myeloid Leukemia or Acute Lymphocytic Leukemia
Chronic Myeloid Leukemia, Acute Lymphocytic Leukemia
Phase 12006-07-01
CompletedA Multicenter, Dose Ranging Safety and Pharmacokinetics Study of Arimoclomol in ALS
Amyotrophic Lateral Sclerosis (ALS)
Phase 22005-10-01
WithdrawnA Multicenter, Double-Blind Study to Investigate the Safety and Efficacy of Arimoclomol in Volunteers With ALS
Amyotrophic Lateral Sclerosis
Phase 2—
No Longer AvailableCompassionate Use of Aldoxorubicin in Sarcoma Patients Chemotherapy
Sarcoma
——